Literature DB >> 7894631

Antineutrophil cytoplasmic antibodies (ANCA) in idiopathic pulmonary hemosiderosis.

A Blanco1, P Solis, S Gomez, C Valbuena, J J Telleria.   

Abstract

Four children were diagnosed with idiopathic pulmonary hemosiderosis (IPH), over a period of 4 years. Retrospectively, antineurtrophil cytoplasmic antibodies (ANCA) were studied by indirect immunofluorescence (IIF) and ELISA in 18 sera from these patients, stored at -20 degrees C. ANCA-positive sera, from 1/20 to 1/1, 200 dilution, were found in 3/4 of the patients, by IIF. The patient with the highest titre of ANCA died 3 months later during an acute crisis, the other two patients need a minimal dose of steroids. In one case only, a patient who is still without treatment, had no ANCA. The antibodies anti-myeloperoxidase and anti-proteinase-3 were negative or at border line levels. Rheumatoid factor, antinuclear (Hep-2), anti-endomysial, anti-reticulin and antibasement membrane antibodies were negative in all sera. The surviving patients were followed-up for more than 10 years with no systemic or renal disease appearances. The presence of serum ANCA may help to classify children with pulmonary haemorrhage and may have a prognostic value.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7894631     DOI: 10.1111/j.1399-3038.1994.tb00246.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  3 in total

1.  Case report of idiopathic pulmonary haemosiderosis in a child with recurrent chest infections.

Authors:  Renan Ibrahem; Anita Arasaretnam; Katherine Ordidge; John Vedelago; Rosemary Toy
Journal:  J Radiol Case Rep       Date:  2011-09-01

2.  Diffuse alveolar haemorrhage associated with subsequent development of ANCA positivity and emphysema in three young adults.

Authors:  Anna Stainer; Alex Rice; Anand Devaraj; Joseph Luke Barnett; Jacqueline Donovan; Maria Kokosi; Andrew Gordon Nicholson; Tom Cairns; Athol Umfrey Wells; Elisabetta Augusta Renzoni
Journal:  BMC Pulm Med       Date:  2019-10-24       Impact factor: 3.320

3.  A physician survey reveals differences in management of idiopathic pulmonary hemosiderosis.

Authors:  Chana I C Chin; Shirleen Loloyan Kohn; Thomas G Keens; Monique F Margetis; Roberta M Kato
Journal:  Orphanet J Rare Dis       Date:  2015-08-20       Impact factor: 4.303

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.